Reverse Takeover of id4 AG by Anemoi International

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM) OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

17 December 2021

Thalassa Holdings Ltd

("Thalassa" or the "Company")

Reverse Takeover of id4 AG by Anemoi International Ltd

The Board of Thalassa Holdings Ltd (LSE:THAL) is pleased to note completion of the acquisition by Anemoi International Ltd ("Anemoi") of id4 AG ("id4").  Thalassa has disposed of its 84% shareholding in id4 (held indirectly through its 100% owned subsidiary, Apeiron Holdings (BVI) Ltd) ("Apeiron") in return for aggregate consideration of £4,480,000 ($5,929,772) to be satisfied 50% on completion and 50% on a deferred basis dependent on the financial performance of id4 over a 5 year period.  On completion of the acquisition today, Anemoi has therefore unconditionally issued 56,000,000 Anemoi shares to Apeiron. Thalassa carrying value of id4 AG was recognized in the latest quarter accounts at $1,287,360, the Board are pleased with the positive contribution that this transaction has on THAL's NAV and the further potential contribution that can be achieved based on id4's future performance.

Further details of the transaction are available in the prospectus published by Anemoi on 13 December 2021 and available on its website at www.anemoi-international.com.

Duncan Soukup, Executive Chairman, commented:

"We are delighted with the successful closing of the AMOI - id4 AG transaction, which now gives id4 the necessary capital to grow sales and achieve profitability. Whilst id4 is still an early-stage growth company, I am happy and grateful for the support received from current and new investors in a difficult market, The AMOI - id4 transaction was a relatively complex cross-border transaction, made more difficult by health-related interruptions during the process, and which, therefore, absorbed significantly more of management's time and effort than anticipated. The completion of this transaction will now give us all more time to focus on THAL's other assets."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.  Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.